TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

First Page		Document Content
Health economics Healthcare quality Immunosuppressants Orphan drugs Costs Disease-modifying antirheumatic drug Tocilizumab Rituximab Quality-adjusted life year Rheumatoid arthritis Etanercept TNF inhibitor		TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS Add to Reading List Source URL: www.nicedsu.org.uk Download Document from Source Website File Size: 229,84 KB Share Document on Facebook

	PDF Document DocID: 1wJbG - View Document
	PDF Document DocID: 1wqI7 - View Document
	Worker Sorting, Taxes and Health Insurance Coverage1 Kevin Lang Boston University and NBER & IZA Dept. of Economics Boston University 270 Bay State Road DocID: 1vkT8 - View Document
	Information on pharmaceutical product quality and physician adoption Katharina Elisabeth Fischer*a,b, Kay Petersa,c and Tom Stargardta a CINCH Health Economics Research Center and Faculty of Business Administration a DocID: 1vdXm - View Document
	Microsoft Word - workshop Hausman - ethics and economics of health care.docx DocID: 1uV5k - View Document